Trial intelligence / Profile preview

Ciclosporin for Recurrent or Chronic Erythema Nodosum Leprosum

NCT00919776Phase 2Completed

Sponsor
London School of Hygiene & Tropical Medicine
Start
Aug 2010
Primary completion
Dec 2012
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cyclosporine in erythema nodosum leprosum (ENL), sponsored by London School of Hygiene & Tropical Medicine. Started Aug 2010; status: completed.

02

Drugs

cyclosporine
03

Conditions

erythema nodosum leprosum (ENL)

Beyond the preview

Go deeper on NCT00919776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00919776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call